These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation]. Sempels C; Sienaert P Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373 [TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Freeman MP Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):291-7. PubMed ID: 16930971 [TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077 [TBL] [Abstract][Full Text] [Related]
5. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485 [TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Wozniak J; Biederman J; Mick E; Waxmonsky J; Hantsoo L; Best C; Cluette-Brown JE; Laposata M Eur Neuropsychopharmacol; 2007; 17(6-7):440-7. PubMed ID: 17258897 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Rees AM; Austin MP; Parker GB Aust N Z J Psychiatry; 2008 Mar; 42(3):199-205. PubMed ID: 18247194 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. McNamara RK Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):223-31. PubMed ID: 19515544 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic use of omega-3 fatty acids in bipolar disorder. Balanzá-Martínez V; Fries GR; Colpo GD; Silveira PP; Portella AK; Tabarés-Seisdedos R; Kapczinski F Expert Rev Neurother; 2011 Jul; 11(7):1029-47. PubMed ID: 21721919 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Sarris J; Mischoulon D; Schweitzer I J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025 [TBL] [Abstract][Full Text] [Related]
12. The role of omega-3 fatty acids in mood disorders. Stahl LA; Begg DP; Weisinger RS; Sinclair AJ Curr Opin Investig Drugs; 2008 Jan; 9(1):57-64. PubMed ID: 18183532 [TBL] [Abstract][Full Text] [Related]
13. Role of omega-3 Fatty acids for prevention or treatment of perinatal depression. Borja-Hart NL; Marino J Pharmacotherapy; 2010 Feb; 30(2):210-6. PubMed ID: 20099994 [TBL] [Abstract][Full Text] [Related]
14. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations. Sarris J; Lake J; Hoenders R J Altern Complement Med; 2011 Oct; 17(10):881-90. PubMed ID: 22010777 [TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. Wozniak J; Faraone SV; Chan J; Tarko L; Hernandez M; Davis J; Woodworth KY; Biederman J J Clin Psychiatry; 2015 Nov; 76(11):1548-55. PubMed ID: 26646031 [TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial. Murphy BL; Stoll AL; Harris PQ; Ravichandran C; Babb SM; Carlezon WA; Cohen BM J Clin Psychopharmacol; 2012 Oct; 32(5):699-703. PubMed ID: 22926607 [TBL] [Abstract][Full Text] [Related]